Real-World Effectiveness of High-Dose Tafamidis on Neurologic Disease Progression in Mixed-Phenotype Variant Transthyretin Amyloid Cardiomyopathy.
Nicholas StreicherLeslie AmassRong WangJennifer M StephensTraci LeMastersRutika RainaEmma MerrillFarooq H SheikhPublished in: Cardiology and therapy (2024)
ClinicalTrials.gov: NCT05139680.